Day: March 2, 2021

GREENWICH, Conn., March 02, 2021 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of supply chain solutions, today announced that another ten XPO less-than-truckload (LTL) drivers surpassed three million accident-free miles in the last six months of 2020:Vincent Black (Georgia), Ronald Boring (Tennessee), Craig Boyd (Tennessee), Joe Caliri (Ohio), Marty Collier (Arkansas), Charles Dangerfield (Virginia), Samuel Gleason (Pennsylvania), Dale Pritchett (Texas), Lee Redfearn (North Carolina) and Michael Stirewalt (North Carolina).An additional 16 XPO drivers reached two million accident-free miles and 125 drivers reached one million accident-free miles in the same period, bringing the annual number of honorees to a record 230 drivers for 2020. All are employed by the company’s North American LTL unit.XPO...

CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) — Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Tuesday, March 9, 2021 to report its fourth quarter and full year 2020 financial results and discuss business highlights.To access the live conference call, please dial 866-795-3242 (domestic) or 409-937-8909 (international) and refer to conference ID 3094547. A live webcast of the event will also be available under “News and Events” in the Investors section of Evelo’s website at http://ir.evelobio.com. The archived webcast will be available on Evelo’s website approximately two hours after the completion of the event and will be available for 30 days following...

DURHAM, N.C., March 02, 2021 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, today announced that Mike Sherman, Chief Executive Officer, will participate in a pre-recorded presentation at the H.C. Wainwright Global Life Sciences Conference made available on Tuesday, March 9, 2021 at 7:00 a.m. ET.An audio webcast of the presentation will be available on the Investor Relations section of Chimerix’s website at ir.chimerix.com, where it will be archived for approximately 90 days.About ChimerixChimerix is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases....

TORONTO, March 02, 2021 (GLOBE NEWSWIRE) — Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that PharmaTher has entered into an exclusive license agreement with The University of Kansas for the development and commercialization for the intellectual property of ketamine in the treatment amyotrophic lateral sclerosis (“ALS”), also known as Lou Gehrig’s disease.The University of Kansas Medical Center inventors Dr. Richard J. Barohn, M.D., John A. Stanford, Ph.D., and Dr. Matthew Macaluso, D.O., have made the promising discovery that ketamine can be administered as an effective treatment for ALS. Their preclinical research...

GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that management will be participating in the following virtual investor conferences:H.C. Wainwright Global Life Sciences Conference ‎(March 9-10, 2021)A fireside chat with Sue Washer, President & Chief Executive Officer, will be available to view on-demand beginning Tuesday, March 9, 2021 at 7:00 a.m. ET through the entirety of the conference.33rd Annual ROTH Conference (March 15-17, 2021)Ms. Washer and Mark Shearman, Chief Scientific Officer, will participate in a fireside chat at 1:00 p.m. ET on Monday, March 15, 2021.Audio webcasts of...

MALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, President and Chief Executive Officer, will give a corporate presentation at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021.The presentation will be made available for on-demand listening beginning Tuesday, March 9th at 7:00 a.m. Eastern Time and may be accessed on the “Presentations” page within the investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. The recording will be made available for a period of 30 days following the event.About Baudax BioBaudax Bio is a pharmaceutical company focused on therapeutics for acute care settings. The launch of Baudax Bio’s...

BALA CYNWYD, Pa., March 02, 2021 (GLOBE NEWSWIRE) — Leading private markets investment management firm Hamilton Lane (NASDAQ: HLNE) today announced the final closing of Hamilton Lane Strategic Opportunities Fund VI (“the Fund”). The Fund represents nearly $900 million in commitments from a wide range of global LPs.The Fund is focused on making credit-oriented investments striving for consistent cash yield, shorter duration and attractive risk-adjusted returns. Consistent with previous vintage vehicles, the Fund is comprised of a diverse set of institutions, including returning as well as new investors from Asia, the Middle East, Europe and North and South America.Drew Schardt, Head of Direct Credit at Hamilton Lane, commented: “The private credit landscape continues to evolve, marked by growing LP interest driven generally by the...

VIRGINIA CITY, Nev., March 02, 2021 (GLOBE NEWSWIRE) — Comstock Mining Inc. (the “Company”) (NYSE: LODE) announced that it has entered into securities purchase agreements for the sale of 4,000,000 shares of its common stock at a price of $4.00 per share in a registered direct offering. No warrants will be issued in connection with the transaction. The closing of the offering is expected to occur on or about March 4, 2021, subject to the satisfaction of customary closing conditions.Noble Capital Markets, Inc. is acting as the sole placement agent for the offering.The Company intends to use the net proceeds from the offering to fund the LINICO Corporation acquisition, previously announced on February 17, 2021, investments in Mercury Clean Up LLC, mineral acquisition and development, and general corporate purposes.The share offering...

LP20-165 intersected 7.0 meters averaging 21.9 g/t Au and 2.7% Cu at Target B;LP20-165 also passed through Target A, intersecting 17.0 meters averaging 6.7 g/t Au and 0.1 % Cu;Low grade mineralization was encountered starting at the andesite-dacite contact, returning 298 metres of 1.21 g/t (includes 48 metres that was not sampled and included at zero grade)LP20-165 is the first hole returned from the deep drilling program: it extended Target B a further 100 m to depth, and extended Target A a further 25m below the previous limitsLP20-177, the first drill hole at Target D, intersected 4.9 meters averaging 1.2 g/t Au with 0.3% Cu suggesting potential to increase this zone at depth.Four drills are currently active: two drills are testing the depth extensions at Target B and C, one drill is testing Target D, and one drill is exploring 4 kilometres...